Abstract
The obesity pandemic has focused attention in recent years to the physiological and molecular mechanisms that regulate body weight and glucose metabolism. Key signaling pathways that regulate both parameters depend heavily on reversible phosphorylation of proteins on tyrosine residues, a process regulated by the opposing activities of tyrosine kinases and tyrosine phosphatases. Here we review the roles of protein tyrosine phosphatase epsilon (PTPe) in regulating the leptin and insulin signaling pathways and through them—body weight and glucose metabolism. Mice lacking PTPe are leptin-hypersensitive and are protected from weight gain that follows a high-fat diet. PTPe helps downregulate leptin receptor signaling in the hypothalamus by dephosphorylating JAK2 following activation of the leptin receptor, thus inhibiting the receptor post-activation. PTPe is induced to perform this function after undergoing leptin receptor-induced phosphorylation at its C-terminal Y695. Mice lacking PTPe are also insulin-hypersensitive, indicating that PTPe downregulates signaling by this receptor as well. Studies in muscle cells confirm that PTPe inhibits insulin receptor signaling, possibly by targeting the receptor itself. These studies identify PTPe as a physiological inhibitor of both signaling pathways and as a factor in supporting the resistance to leptin and insulin that is established in obesity and in type-II diabetes, respectively.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AgRP:
-
Agouti-related protein
- BHK:
-
Baby hamster kidney
- CD:
-
Chow diet
- Cyt-PTPe:
-
Cytosolic isoform of PTPe
- EKO:
-
PTPe-knockout
- ERK:
-
Extracellular signal-regulated kinase
- GSK:
-
Glycogen synthase kinase
- HFD:
-
High-fat diet
- PEPCK:
-
Phosphoenolpyruvate carboxykinase
- PKB:
-
Protein kinase B
- POMC:
-
Pro-opiomelanocortin
- PTK:
-
Protein tyrosine kinase
- PTP:
-
Protein tyrosine phosphatase
- PTPe:
-
Protein tyrosine phosphatase epsilon
- RPTPe:
-
Receptor-type isoform of PTPe
- RPTPs:
-
Receptor-type PTPs
- WT:
-
Wild-type
References
Hunter T (2000) Signaling—2000 and beyond. Cell 100(1):113–127
Lemmon MA, Schlessinger J (2010) Cell signaling by receptor tyrosine kinases. Cell 141(7):1117–1134
Alonso A, Sasin J, Bottini N, Friedberg I, Osterman A, Godzik A et al (2004) Protein tyrosine phosphatases in the human genome. Cell 117(6):699–711
Barford D, Das AK, Egloff MP (1998) The structure and mechanism of protein phosphatases: insights into catalysis and regulation. Annu Rev Biophys Biomol Struct 27:133–164
Tonks NK (2006) Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol 7(11):833–846
Navis AC, van den Eijnden M, Schepens JT, Hooft van Huijsduijnen R, Wesseling P, Hendriks WJ (2010) Protein tyrosine phosphatases in glioma biology. Acta Neuropathol 119(2): 157–175
Vang T, Miletic AV, Arimura Y, Tautz L, Rickert RC, Mustelin T (2008) Protein tyrosine phosphatases in autoimmunity. Annu Rev Immunol 26:29–55
Hendriks WJ, Elson A, Harroch S, Stoker AW (2008) Protein tyrosine phosphatases: functional inferences from mouse models and human diseases. FEBS J 275(5):816–830
Pulido R, Hooft van Huijsduijnen R (2008) Protein tyrosine phosphatases: dual-specificity phosphatases in health and disease. FEBS J 275(5):848–866
den Hertog J, Ostman A, Bohmer FD (2008) Protein tyrosine phosphatases: regulatory mechanisms. FEBS J 275(5):831–847
Barr AJ (2010) Protein tyrosine phosphatases as drug targets: strategies and challenges of inhibitor development. Future Med Chem 2(10):1563–1576
Scott LM, Lawrence HR, Sebti SM, Lawrence NJ, Wu J (2010) Targeting protein tyrosine phosphatases for anticancer drug discovery. Curr Pharm Des 16(16):1843–1862
Haque A, Andersen JN, Salmeen A, Barford D, Tonks NK (2011) Conformation-sensing antibodies stabilize the oxidized form of PTP1B and inhibit its phosphatase activity. Cell 147(1): 185–198
Elson A, Leder P (1995) Protein-tyrosine phosphatase epsilon. An isoform specifically expressed in mouse mammary tumors initiated by v-Ha-ras OR neu. J Biol Chem 270(44):26116–26122
Krueger NX, Streuli M, Saito H (1990) Structural diversity and evolution of human receptor-like protein tyrosine phosphatases. EMBO J 9:3241–3252
Lim KL, Lai DS, Kalousek MB, Wang Y, Pallen CJ (1997) Kinetic analysis of two closely related receptor-like protein-tyrosine-phosphatases, PTP alpha and PTP epsilon. Eur J Biochem 245(3):693–700
Nakamura K, Mizuno Y, Kikuchi K (1996) Molecular cloning of a novel cytoplasmic protein tyrosine phosphatase PTP epsilon. Biochem Biophys Res Commun 218:726–732
Elson A, Leder P (1995) Identification of a cytoplasmic, phorbol ester-inducible isoform of protein tyrosine phosphatase epsilon. Proc Natl Acad Sci U S A 92(26):12235–12239
Tanuma N, Nakamura K, Kikuchi K (1999) Distinct promoters control transmembrane and cytosolic protein tyrosine phosphatase epsilon expression during macrophage differentiation. Eur J Biochem 259:46–54
Gil-Henn H, Volohonsky G, Elson A (2001) Regulation of protein-tyrosine phosphatases alpha and epsilon by calpain-mediated proteolytic cleavage. J Biol Chem 276(34):31772–31779
Gil-Henn H, Volohonsky G, Toledano-Katchalski H, Gandre S, Elson A (2000) Generation of novel cytoplasmic forms of protein tyrosine phosphatase epsilon by proteolytic processing and translational control. Oncogene 19(38):4375–4384
Kraut J, Volohonsky G, Toledano-Katchalski H, Elson A (2002) Nuclear localization of non-receptor protein tyrosine phosphatase epsilon is regulated by its unique N-terminal domain. Exp Cell Res 281(2):182–189
Elson A (1999) Protein tyrosine phosphatase epsilon increases the risk of mammary hyperplasia and mammary tumors in transgenic mice. Oncogene 18(52):7535–7542
Berman-Golan D, Elson A (2007) Neu-mediated phosphorylation of protein tyrosine phosphatase epsilon is critical for activation of Src in mammary tumor cells. Oncogene 26(49): 7028–7037
Gil-Henn H, Elson A (2003) Tyrosine phosphatase-epsilon activates Src and supports the transformed phenotype of Neu-induced mammary tumor cells. J Biol Chem 278(18): 15579–15586
Peretz A, Gil-Henn H, Sobko A, Shinder V, Attali B, Elson A (2000) Hypomyelination and increased activity of voltage-gated K(+) channels in mice lacking protein tyrosine phosphatase epsilon. EMBO J 19:4036–4045
Tiran Z, Peretz A, Attali B, Elson A (2003) Phosphorylation-dependent regulation of Kv2.1 Channel activity at tyrosine 124 by Src and by protein-tyrosine phosphatase epsilon. J Biol Chem 278(19):17509–17514
Muja N, Lovas G, Romm E, Machleder D, Ranjan M, Gallo V et al (2004) Expression of a catalytically inactive transmembrane protein tyrosine phosphatase epsilon (tm-PTP epsilon) delays optic nerve myelination. Glia 48(4):278–297
Chiusaroli R, Knobler H, Luxenburg C, Sanjay A, Granot-Attas S, Tiran Z et al (2004) Tyrosine phosphatase epsilon is a positive regulator of osteoclast function in vitro and in vivo. Mol Biol Cell 15(1):234–244
Kollet O, Dar A, Shivtiel S, Kalinkovich A, Lapid K, Sztainberg Y et al (2006) Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med 12(6):657–664
Granot-Attas S, Luxenburg C, Finkelshtein E, Elson A (2009) PTP epsilon regulates integrin-mediated podosome stability in osteoclasts by activating Src. Mol Biol Cell 20(20):4324–4334
Boyce BF, Yoneda T, Lowe C, Soriano P, Mundy GR (1992) Requirement of pp 60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J Clin Invest 90(4):1622–1627
Destaing O, Sanjay A, Itzstein C, Horne WC, Toomre D, De Camilli P et al (2008) The tyrosine kinase activity of c-Src regulates actin dynamics and organization of podosomes in osteoclasts. Mol Biol Cell 19(1):394–404
Toledano-Katchalski H, Kraut J, Sines T, Granot-Attas S, Shohat G, Gil-Henn H et al (2003) Protein tyrosine phosphatase epsilon inhibits signaling by mitogen-activated protein kinases. Mol Cancer Res 1(7):541–550
Wabakken T, Hauge H, Finne EF, Wiedlocha A, Aasheim H (2002) Expression of human protein tyrosine phosphatase epsilon in leucocytes: a potential ERK pathway-regulating phosphatase. Scand J Immunol 56(2):195–203
Tanuma N, Nakamura K, Shima H, Kikuchi K (2000) Protein-tyrosine phosphatase PTPepsilon C inhibits Jak-STAT signaling and differentiation induced by interleukin-6 and leukemia inhibitory factor in M1 leukemia cells. J Biol Chem 275:28216–28221
Tanuma N, Shima H, Nakamura K, Kikuchi K (2001) Protein tyrosine phosphatase epsilonC selectively inhibits interleukin-6- and interleukin- 10-induced JAK-STAT signaling. Blood 98:3030–3034
Tanuma N, Shima H, Shimada S, Kikuchi K (2003) Reduced tumorigenicity of murine leukemia cells expressing protein-tyrosine phosphatase, PTPepsilon C. Oncogene 22(12): 1758–1762
Sully V, Pownall S, Vincan E, Bassal S, Borowski AH, Hart PH et al (2001) Functional abnormalities in protein tyrosine phosphatase epsilon-deficient macrophages. Biochem Biophys Res Commun 286:184–188
Thompson LJ, Jiang J, Madamanchi N, Runge MS, Patterson C (2001) PTP-epsilon, a tyrosine phosphatase expressed in endothelium, negatively regulates endothelial cell proliferation. Am J Physiol Heart Circ Physiol 281:H396–H403
De Franceschi L, Biondani A, Carta F, Turrini F, Laudanna C, Deana R et al (2008) PTPepsilon has a critical role in signaling transduction pathways and phosphoprotein network topology in red cells. Proteomics 8(22):4695–4708
Spiegelman BM, Flier JS (2001) Obesity and the regulation of energy balance. Cell 104(4):531–543
Wauman J, Tavernier J (2011) Leptin receptor signaling: pathways to leptin resistance. Front Biosci 17:2771–2793
Myers MG, Cowley MA, Munzberg H (2008) Mechanisms of leptin action and leptin resistance. Annu Rev Physiol 70:537–556
Myers MG Jr, Munzberg H, Leinninger GM, Leshan RL (2009) The geometry of leptin action in the brain: more complicated than a simple ARC. Cell Metab 9(2):117–123
Morris DL, Rui L (2009) Recent advances in understanding leptin signaling and leptin resistance. Am J Physiol Endocrinol Metab 297(6):E1247–E1259
Bence KK, Delibegovic M, Xue B, Gorgun CZ, Hotamisligil GS, Neel BG et al (2006) Neuronal PTP1B regulates body weight, adiposity and leptin action. Nat Med 12(8):917–924
Cheng A, Uetani N, Simoncic PD, Chaubey VP, Lee-Loy A, McGlade CJ et al (2002) Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. Dev Cell 2(4):497–503
Zabolotny JM, Bence-Hanulec KK, Stricker-Krongrad A, Haj F, Wang Y, Minokoshi Y et al (2002) PTP1B regulates leptin signal transduction in vivo. Dev Cell 2(4):489–495
Loh K, Fukushima A, Zhang X, Galic S, Briggs D, Enriori PJ et al (2011) Elevated hypothalamic TCPTP in obesity contributes to cellular leptin resistance. Cell Metab 14(5):684–699
Krajewska M, Banares S, Zhang EE, Huang X, Scadeng M, Jhala US et al (2008) Development of diabesity in mice with neuronal deletion of Shp2 tyrosine phosphatase. Am J Pathol 172(5):1312–1324
Zhang EE, Chapeau E, Hagihara K, Feng GS (2004) Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism. Proc Natl Acad Sci U S A 101(45):16064–16069
He Z, Zhang SS, Meng Q, Li S, Zhu HH, Raquil MA et al (2012) Shp2 controls female body weight and energy balance by integrating leptin and estrogen signals. Mol Cell Biol 32(10):1867–1878
Banno R, Zimmer D, De Jonghe BC, Atienza M, Rak K, Yang W et al (2010) PTP1B and SHP2 in POMC neurons reciprocally regulate energy balance in mice. J Clin Invest 120(3):720–734
Rousso-Noori L, Knobler H, Levy-Apter E, Kuperman Y, Neufeld-Cohen A, Keshet Y et al (2011) Protein tyrosine phosphatase epsilon affects body weight by downregulating leptin signaling in a phosphorylation-dependent manner. Cell Metab 13(5):562–572
Sines T, Granot-Attas S, Weisman-Welcher S, Elson A (2007) Association of tyrosine phosphatase epsilon with microtubules inhibits phosphatase activity and is regulated by the epidermal growth factor receptor. Mol Cell Biol 27(20):7102–7112
Belgardt BF, Bruning JC (2010) CNS leptin and insulin action in the control of energy homeostasis. Ann N Y Acad Sci 1212:97–113
Clegg DJ, Riedy CA, Smith KA, Benoit SC, Woods SC (2003) Differential sensitivity to central leptin and insulin in male and female rats. Diabetes 52(3):682–687
Shi H, Seeley RJ, Clegg DJ (2009) Sexual differences in the control of energy homeostasis. Front Neuroendocrinol 30(3):396–404
Andersen JN, Elson A, Lammers R, Romer J, Clausen JT, Moller KB et al (2001) Comparative study of protein tyrosine phosphatase-epsilon isoforms: membrane localization confers specificity in cellular signalling. Biochem J 354(Pt 3):581–590
Nakagawa Y, Aoki N, Aoyama K, Shimizu H, Shimano H, Yamada N et al (2005) Receptor-type protein tyrosine phosphatase epsilon (PTPepsilonM) is a negative regulator of insulin signaling in primary hepatocytes and liver. Zoolog Sci 22(2):169–175
Aga-Mizrachi S, Brutman-Barazani T, Jacob AI, Bak A, Elson A, Sampson SR (2008) Cytosolic protein tyrosine phosphatase-epsilon is a negative regulator of insulin signaling in skeletal muscle. Endocrinology 149(2):605–614
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Elson, A. (2013). Protein Tyrosine Phosphatase Epsilon as a Regulator of Body Weight and Glucose Metabolism. In: Bence, K. (eds) Protein Tyrosine Phosphatase Control of Metabolism. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7855-3_10
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7855-3_10
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-7854-6
Online ISBN: 978-1-4614-7855-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)